FY19. Base award. Nida clinical trials research coordination center REF. # N01DA-19-2249. Period of performance: 08/27/2019 to 08/26/2020.

Ended Definitive Contract Awarded Last action

Contract number
75N95019C00054
Awardee
Awarding agency
Obligated
$1,745,869

Award facts

Opportunity
  • 75N95019R00038 Solicitation number
Contract value 100% obligated
$1,745,869.38 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
8(a) Sole Source
Competition
Not Available for Competition · 1 offer Only One Source
Pricing
Cost Plus Fixed Fee
Place of performance
Silver Spring, MD 20910, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00011 · FY26 UDO initiative. Nida clinical trials research coordination center. 8/27/2019 - 8/26/2024. -$3
Funding Only Action P00010 · To administratively deobligate remaining fiscal years 2020-2023 expiring funding. -$16,363
Other Administrative Action P00009 $0
Funding Only Action P00008 · Deobligation. To administratively deobligate $128.41 from line no. 1 in expiring fiscal year 2019 funds. Nida clinical trials research coordination center. -$128
Exercise an Option P00007 $70,813
Exercise an Option P00006 · Nida clinical trials research coordination center. August 27, 2019 - august 26, 2024. N01DA-19-2249. $301,488
Exercise an Option P00005 · Nida clinical trials research coordination center REF. # N01DA-19-2249. $230,983
Other Administrative Action P00004 $0
Exercise an Option P00003 · FY23. OP3. Nida clinical trials research coordination center REF. # N01DA-19-2249. Period of performance: 08/27/2022 to 08/26/2023. $289,707
Exercise an Option P00002 · FY21. OP2. Nida clinical trials research coordination center REF. # N01DA-19-2249. Period of performance: 08/27/2021 to 08/26/2022. $289,756
Exercise an Option P00001 · FY20. OP1. Nida clinical trials research coordination center REF. # N01DA-19-2249. Period of performance: 08/27/2020 to 08/26/2021. $289,795
Original award $289,822
Show all 12

About this award

The National Institute on Drug Abuse awarded a definitive contract to Leed Management Consulting Inc. for clinical trials research coordination on August 27, 2019, under an 8(a) sole source set-aside, with a ceiling value of $1,745,869.38.

The contract covers the NIDA Clinical Trials Research Coordination Center, with place of performance in Silver Spring, MD. The base period ran from August 27, 2019 to August 26, 2020; the contract was extended through August 26, 2024 under the FY26 UDO initiative. The contract is priced on a cost-plus-fixed-fee basis.

Service Contract Inventory data shows declining labor intensity and hourly rates across the reported performance period. FY2023, the most recent reported year, reflects 0.8 FTEs and 1,614 contractor hours invoiced at a derived rate of $64.09 per hour. The prime self-performed all reported hours with no subcontractors. FY2022 invoiced $300 thousand across 1.4 FTEs and 2,925 contractor hours at $102.70 per hour, and FY2021 invoiced $250 thousand across 0.9 FTEs and 1,807 contractor hours at $138.50 per hour.

Quick answers

Who was awarded contract 75N95019C00054?

75N95019C00054 was awarded to Leed Management Consulting Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 27, 2019.

How much is contract 75N95019C00054 worth?

The government has obligated $1,745,869 on 75N95019C00054.

Was contract 75N95019C00054 competed?

The extent of competition for 75N95019C00054 was not available for competition. The government received 1 offer. It was set aside: 8(a) Sole Source.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award